Menu

绥美凯可以抗艾滋吗

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Can it fight AIDS?

Suimeike (Dolutea Paramid Tablets, Inbec) is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40 kg) infected with human immunodeficiency virus (HIV). HIV-infected patients, regardless of race, should be screened for the HLA-B5701 allele before starting treatment with abacavir-containing products. If the patient is known to carry the HLA-B5701 allele, he should not take products containing abacavir.

Suimeike (Dolutegravir Tablets, Inbec) is currently the only three-in-one compound drug containing dolutegravir (DTG). One tablet contains three antiviral drugs. Treatment drugs for different stages of viral infection are integrated in the same tablet. One tablet is a complete treatment plan. One tablet per day can achieve the effect of cocktail therapy without food restrictions.

AIDS is a chronic infectious disease, and medication compliance is very important for patients. Inbec (Inbec) is China's first complete single-piece three-in-one preparation with DTG as the core, filling the gap in single-piece compound preparations. Taking one pill once a day reduces the frequency and dosage of medication and significantly enhances patient compliance.

Taking TRIUMEQ (TRIUMEQ) for treatment will also produce certain side effects or adverse reactions, including: nausea/insomnia/dizziness/headache, etc. Before receiving this drug for treatment, patients must go to the hospital for a detailed examination and take the drug according to the doctor's diagnosis and treatment recommendations. Patients with abacavir hypersensitivity often experience symptoms such as nausea/vomiting/diarrhoea/fever/drowsiness/rash when using TRIUMEQ. If patients experience these symptoms, they should be carefully evaluated for the presence of such a hypersensitivity reaction.

The above is the introduction about (TRIUMEQ), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/80739.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。